Advertisement
Heart, Lung and Circulation

Ten Years of Percutaneous Pulmonary Valve Implantation in Australia and New Zealand

Published:August 26, 2022DOI:https://doi.org/10.1016/j.hlc.2022.07.008

      Objective

      This study sought to investigate the characteristics, morbidity (including the rate of infective endocarditis and valve replacement) and mortality of individuals undergoing percutaneous pulmonary valve implantation in Australia and New Zealand since the procedure has been performed.

      Background

      The outcomes of percutaneous pulmonary valve implantation in Australia and New Zealand have not been evaluated. Recent international data, including patients from New Zealand, suggests the rate of infective endocarditis is not insignificant.

      Methods

      A retrospective multi-site cohort study was undertaken via medical record review at the centres where percutaneous pulmonary valve implantation has been performed. All procedures performed from 2009—March 2018 were included. Individuals were identified from local institution databases. Data was collected and analysed including demographics, details at the time of intervention, haemodynamic outcome, post procedure morbidity and mortality. Multi-site ethics approval was obtained.

      Results

      One hundred and seventy-nine (179) patients attended the cardiac catheter laboratory for planned percutaneous pulmonary valve implantation. Of these patients, 172 underwent successful implantation. Tetralogy of Fallot and pulmonary atresia were the most common diagnoses. The median age at procedure was 19 years (range 3–60 yrs). There was a significant improvement in the acute haemodynamics in patients undergoing percutaneous pulmonary valve implantation for stenosis. Seven (7) patients (3.9%) experienced a major procedural/early post procedure complication (death, conversion to open procedure, cardiac arrest), including two deaths. The annualised rates of infective endocarditis and valve replacement were 4.6% and 3.8% respectively. There was one death related to infective endocarditis in follow-up.

      Conclusions

      Percutaneous pulmonary valve replacement is a relatively safe method of rehabilitating the right ventricular outflow tract.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Heart, Lung and Circulation
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

      1. Medtronic. Melody™ TPV/ Ensemble™ II Delivery System 2020. Available from: https://www.medtronic.com/us-en/healthcare-professionals/products/cardiovascular/transcatheter-pulmonary-valve/melody-ensemble-system.html.

        • Lurz Y.P.
        • Coats M.L.
        • Khambadkone M.S.
        • Nordmeyer M.J.
        • Boudjemline M.Y.
        • Schievano M.S.
        • et al.
        Percutaneous pulmonary valve implantation: impact of evolving technology and learning curve on clinical outcome.
        Circulation. 2008; 117: 1964-1972
        • Zahn E.M.
        • Hellenbrand W.E.
        • Lock J.E.
        • McElhinney D.B.
        Implantation of the melody transcatheter pulmonary valve in patients with a dysfunctional right ventricular outflow tract conduit early results from the U.S. clinical trial.
        J Am Coll Cardiol. 2009; 54: 1722-1729
        • Ansari M.M.
        • Cardoso R.
        • Garcia D.
        • Sandhu S.
        • Horlick E.
        • Brinster D.
        • et al.
        Percutaneous pulmonary valve implantation: present status and evolving future.
        J Am Coll Cardiol. 2015; 66: 2246-2255
        • Gillespie J.M.
        • Rome J.J.
        • Levi S.D.
        • Williams J.R.
        • Rhodes F.J.
        • Cheatham P.J.
        • et al.
        Melody valve implant within failed bioprosthetic valves in the pulmonary position: a multicenter experience.
        Circ Cardiovasc Interv. 2012; 5: 862-870
        • Meadows J.J.
        • Moore M.P.
        • Berman P.D.
        • Cheatham P.J.
        • Cheatham L.S.
        • Porras J.D.
        • et al.
        Use and performance of the Melody transcatheter pulmonary valve in native and postsurgical, nonconduit right ventricular outflow tracts.
        Circ Cardiovasc Interv. 2014; 7: 374-380
        • Ran L.
        • Wang W.
        • Secchi F.
        • Xiang Y.
        • Shi W.
        • Huang W.
        Percutaneous pulmonary valve implantation in patients with right ventricular outflow tract dysfunction: a systematic review and meta-analysis.
        Ther Adv Chronic Dis. 2019; 102040622319857635
        • Nordmeyer J.
        • Ewert P.
        • Gewillig M.
        • Aljufan M.
        • Carminati M.
        • Kretschmar O.
        • et al.
        Acute and midterm outcomes of the post-approval MELODY Registry: a multicentre registry of transcatheter pulmonary valve implantation.
        Eur Heart J. 2019; 40: 2255
        • Abdelghani M.
        • Nassif M.
        • Blom N.A.
        • Van Mourik M.S.
        • Straver B.
        • Koolbergen D.R.
        • et al.
        Infective endocarditis after Melody valve implantation in the pulmonary position: a systematic review.
        J Am Heart Assoc. 2018; 7e008163
        • O’Donnell C.
        • Holloway R.
        • Tilton E.
        • Stirling J.
        • Finucane K.
        • Wilson N.
        Infective endocarditis following Melody valve implantation: comparison with a surgical cohort.
        Cardiol Young. 2016; : 1-8
        • Lawley C.
        • Tanous D.
        • Roberts P.
        Percutaneous pulmonary valve implantation: the New South Wales experience.
        Heart Lung Circ. 2018; 27 (S62-S)
        • Markham R.
        • Challa A.
        • Kyranis S.
        • Nicolae M.
        • Murdoch D.
        • Savage M.
        • et al.
        Outcomes following Melody transcatheter pulmonary valve implantation for right ventricular outflow tract dysfunction in repaired congenital heart disease: first reported Australian single centre experience.
        Heart Lung Circ. 2017; 26: 1085-1093
        • Armstrong A.K.
        • Balzer D.T.
        • Cabalka A.K.
        • Gray R.G.
        • Javois A.J.
        • Moore J.W.
        • et al.
        One-year follow-up of the Melody transcatheter pulmonary valve multicenter post-approval study.
        JACC Cardiovasc Interv. 2014; 7: 1254-1262
        • Georgiev S.
        • Ewert P.
        • Tanase D.
        • Hess J.
        • Hager A.
        • Cleuziou J.
        • et al.
        A Low Residual pressure gradient yields excellent long-term outcome after percutaneous pulmonary valve implantation.
        JACC Cardiovasc Interv. 2019; 12: 1594-1603
        • Butera G.
        • Milanesi O.
        • Spadoni I.
        • Piazza L.
        • Donti A.
        • Ricci C.
        • et al.
        Melody transcatheter pulmonary valve implantation. Results from the registry of the Italian society of pediatric cardiology.
        Catheter Cardiovasc Interv. 2013; 81: 310-316
        • McElhinney D.B.
        • Hellenbrand W.E.
        • Zahn E.M.
        • Jones T.K.
        • Cheatham J.P.
        • Lock J.E.
        • et al.
        Short- and medium-term outcomes after transcatheter pulmonary valve placement in the expanded multicenter US Melody valve trial.
        Circulation. 2010; 122: 507-516
        • Eicken A.
        • Ewert P.
        • Hager A.
        • Peters B.
        • Fratz S.
        • Kuehne T.
        • et al.
        Percutaneous pulmonary valve implantation: two-centre experience with more than 100 patients.
        Eur Heart J. 2011; 32: 1260-1265
        • Biernacka E.K.
        • Rużyłło W.
        • Demkow M.
        Percutaneous pulmonary valve implantation - state of the art and Polish experience.
        Postepy Kardiol Interwencyjnej. 2017; 13: 3-9
        • Enezate T.
        • Omran J.
        • Bhatt D.L.
        Percutaneous versus surgical pulmonic valve implantation for right ventricular outflow tract dysfunction.
        Cardiovasc Revasc Medicine. 2019; 20: 553-558
        • Khanna A.D.
        • Hill K.D.
        • Pasquali S.K.
        • Wallace A.S.
        • Masoudi F.A.
        • Jacobs M.L.
        • et al.
        Benchmark outcomes for pulmonary valve replacement using The Society of Thoracic Surgeons databases.
        Ann Thorac Surg. 2015; 100: 138-146
        • McKenzie E.D.
        • Khan M.S.
        • Dietzman T.W.
        • Guzmán-Pruneda F.A.
        • Samayoa A.X.
        • Liou A.
        • et al.
        Surgical pulmonary valve replacement: a benchmark for outcomes comparisons.
        J Thorac Cardiovasc Surg. 2014; 148: 1450-1453
        • Babu-Narayan S.V.
        • Diller G.-P.
        • Gheta R.R.
        • Bastin A.J.
        • Karonis T.
        • Li W.
        • et al.
        Clinical outcomes of surgical pulmonary valve replacement after repair of tetralogy of Fallot and potential prognostic value of preoperative cardiopulmonary exercise testing.
        Circulation. 2014; 129: 18-27
        • Sabate Rotes A.
        • Eidem B.W.
        • Connolly H.M.
        • Bonnichsen C.R.
        • Rosedahl J.K.
        • Schaff H.V.
        • et al.
        Long-term follow-up after pulmonary valve replacement in repaired tetralogy of Fallot.
        Am J Cardiol. 2014; 114: 901-908
        • Sharma V.
        • Griffiths E.R.
        • Eckhauser A.W.
        • Gray R.G.
        • Martin M.H.
        • Zhang C.
        • et al.
        Pulmonary valve replacement: a single-institution comparison of surgical and transcatheter valves.
        Ann Thorac Surg. 2018; 106: 807-813
        • O’Donnell C.
        • Holloway R.
        • Tilton E.
        • Stirling J.
        • Finucane K.
        • Wilson N.
        Infective endocarditis following Melody valve implantation: comparison with a surgical cohort.
        . 2017; 27: 294-301
        • Fraisse A.
        • Aldebert P.
        • Malekzadeh-Milani S.
        • Thambo J.-B.
        • Piéchaud J.-F.
        • Aucoururier P.
        • et al.
        Melody® transcatheter pulmonary valve implantation: results from a French registry.
        Arch Cardiovasc Dis. 2014; 107: 607-614
        • Villafañe J.
        • Baker G.H.
        • Austin E.H.
        • Miller S.
        • Peng L.
        • Beekman R.
        Melody ® pulmonary valve bacterial endocarditis: Experience in four pediatric patients and a review of the literature.
        Cathet Cardiovasc Interv. 2014; 84: 212-218
        • Malekzadeh-Milani S.
        • Ladouceur M.
        • Patel M.
        • Boughenou F.-M.
        • Iserin L.
        • Bonnet D.
        • et al.
        Incidence and predictors of Melody® valve endocarditis: A prospective study.
        Arch Cardiovasc Dis. 2015; 108: 97-106
        • McElhinney B.D.
        • Benson N.L.
        • Eicken F.A.
        • Kreutzer M.J.
        • Padera M.R.
        • Zahn M.E.
        Infective endocarditis after transcatheter pulmonary valve replacement using the Melody valve: combined results of 3 prospective North American and European Studies.
        Circ Cardiovasc Interv. 2013; 6: 292-300
        • Sharma A.
        • Cote A.T.
        • Hosking M.C.K.
        • Harris K.C.
        A systematic review of infective endocarditis in patients with bovine jugular vein valves compared with other valve types.
        JACC Cardiovasc Interv. 2017; 10: 1449-1458
        • Beckerman Z.
        • De León L.E.
        • Zea-Vera R.
        • Mery C.M.
        • Fraser Jr., C.D.
        High incidence of late infective endocarditis in bovine jugular vein valved conduits.
        J Thorac Cardiovasc Surg. 2018; 156: 728-734.e2
        • Van Dijck I.
        • Budts W.
        • Cools B.
        • Eyskens B.
        • Boshoff D.E.
        • Heying R.
        • et al.
        Infective endocarditis of a transcatheter pulmonary valve in comparison with surgical implants.
        Heart. 2015; 101: 788-793
        • Saxena A.
        • Salve G.G.
        • Betts K.
        • Arora N.
        • Cole A.D.
        • Sholler G.F.
        • et al.
        Outcomes following heterotopic placement of right ventricle to pulmonary artery conduits.
        World J Pediatr Congenit Heart Surg. 2021; 12: 220-229
        • Uebing A.
        • Rigby M.L.
        The problem of infective endocarditis after transcatheter pulmonary valve implantation.
        Heart. 2015; 101: 749-751
        • Hascoet S.
        • Mauri L.
        • Claude C.
        • Fournier E.
        • Lourtet J.
        • Riou J.-Y.
        • et al.
        Infective endocarditis risk after percutaneous pulmonary valve implantation with the Melody and Sapien valves.
        JACC Cardiovasc Interv. 2017; 10: 510-517
        • Otto C.M.
        • Nishimura R.A.
        • Bonow R.O.
        • Carabello B.A.
        • Erwin J.P.
        • Gentile F.
        • et al.
        2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.
        Circulation. 2021; 143: e72-e227
        • Shibbani K.
        • Garg R.
        • Zahn E.M.
        • McLennan D.
        Aspirin use and transcatheter pulmonary valve replacement, the need for consistency.
        Pediatr Cardiol. 2021; 42: 1640-1646
      2. Infective Endocarditis Prophylaxis Expert Group. Prevention of Endocarditis: 2008 Update from Therapeutic Guidelines 2008. Available from: https://www.csanz.edu.au/wp-content/uploads/2014/12/Prevention_of_Endocarditis_2008.pdfm. [accessed 14.8.22].

        • Kenny D.
        • Rhodes J.F.
        • Fleming G.A.
        • Kar S.
        • Zahn E.M.
        • Vincent J.
        • et al.
        3-year outcomes of the Edwards SAPIEN transcatheter heart valve for conduit failure in the pulmonary position from the COMPASSION multicenter clinical trial.
        JACC Cardiovasc Interv. 2018; 11: 1920-1929
        • Wilson W.M.
        • Benson L.N.
        • Osten M.D.
        • Shah A.
        • Horlick E.M.
        Transcatheter pulmonary valve replacement with the Edwards Sapien system: the Toronto experience.
        JACC Cardiovasc Interv. 2015; 8: 1819-1827
        • Martin M.H.
        • Meadows J.
        • McElhinney D.B.
        • Goldstein B.H.
        • Bergersen L.
        • Qureshi A.M.
        • et al.
        Safety and feasibility of Melody transcatheter pulmonary valve replacement in the native right ventricular outflow tract.
        JACC Cardiovasc Interv. 2018; 11: 1642-1650
      3. United States Food and Drug Administration. Summary of Safety and Effectiveness Data PMA P140017/S005 2017. Available from: https://www.accessdata.fda.gov/cdrh_docs/pdf14/p140017s005b.pdf.

        • Khambadkone S.
        • Burch M.
        • Fenton M.
        • Derrick G.
        • Thiruchelvam T.
        • Karimova A.
        • et al.
        Melody valve in aortic position to facilitate mechanical circulatory support as a bridge to cardiac transplantation.
        Ann Thorac Surg. 2020; 109: e325-e327
        • Hofmann M.
        • Dave H.
        • Hübler M.
        • Kretschmar O.
        Simplified surgical-hybrid Melody® valve implantation for paediatric mitral valve disease.
        Eur J Cardiothorac Surg. 2014; 47: 926-928
        • Breatnach C.R.
        • McGuinness J.
        • Ng L.Y.
        • Franklin O.
        • Redmond M.
        • Nölke L.
        • et al.
        Procedural technique for hybrid pulmonary valve replacement in infants and small children.
        Eur J Cardiothorac Surg. 2020; 59: 823-830
        • Shahanavaz S.
        • Balzer D.
        • Babaliaros V.
        • Kim D.
        • Dimas V.
        • Veeram Reddy S.R.
        • et al.
        Alterra adaptive prestent and SAPIEN 3 THV for congenital pulmonic valve dysfunction: an early feasibility study.
        JACC Cardiovasc Interv. 2020; 13: 2510-2524
        • Cheatham J.
        Pulmonary regurgitation – results from the Harmony™ transcatheter pulmonary valve trial.
        Heart Int. 2020; 14: 67
        • Promphan W.
        • Prachasilchai P.
        • Siripornpitak S.
        • Qureshi S.A.
        • Layangool T.
        Percutaneous pulmonary valve implantation with the Venus P-valve: clinical experience and early results.
        Cardiol Young. 2016; 26: 698-710
        • Sivakumar K.
        • Sagar P.
        • Qureshi S.
        • Promphan W.
        • Sasidharan B.
        • Awasthy N.
        • et al.
        Outcomes of Venus P-valve for dysfunctional right ventricular outflow tracts from Indian Venus P-valve database.
        Ann Pediatr Cardiol. 2021; 14: 281-292
        • Kim G.B.
        • Song M.K.
        • Bae E.J.
        • Park E.A.
        • Lee W.
        • Lim H.G.
        • et al.
        Successful feasibility human trial of a new self-expandable percutaneous pulmonary valve (Pulsta valve) implantation using knitted nitinol wire backbone and trileaflet α-Gal-free porcine pericardial valve in the native right ventricular outflow tract.
        Circ Cardiovasc Interv. 2018; 11e006494
        • Kim A.Y.
        • Jung J.W.
        • Jung S.Y.
        • Shin J.I.
        • Eun L.Y.
        • Kim N.K.
        • et al.
        Early outcomes of percutaneous pulmonary valve implantation with Pulsta and Melody valves: the first report from Korea.
        J Clin Med. 2020; 9: 2769